NasdaqOn RegSHO · 9 days in a row
$0.1449▼ 1.16%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $346,095.97Shares out 2.4M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
36- 10.14After-hours26.10.15 06:21PRE 14COther#●●●#●●●#●●●
Sunshine Biopharma Inc.Bullish
Sunshine Biopharma closed a $6 million public offering on October 9, 2026, issuing common and pre-funded units with Series D warrants. The company has obtained shareholder approval for warrant provisions to ensure compliance with Nasdaq listing rules, allowing for future adjustments to exercise prices and share counts. This approval may lead to significant dilution of existing shareholders upon the exercise of these warrants.…more
$0.1449-1.16%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 10.14After-hours26.10.15 05:058-KKey event
Sunshine Biopharma Inc.
Sunshine Biopharma's CEO, Dr. Steve N. Slilaty, approved the issuance of common stock exceeding 20% of outstanding shares related to the public offering closed on October 9, 2026, via written consent. The consent also authorizes adjustments to the exercise price and share counts of Series D Warrants, including provisions for share combination events. As the CEO holds approximately 90% of the voting power, these actions are effectively finalized and will become effective 20 days after the mailing of the information statement.…more
$0.1449-1.16%vs prev closeView filingShare - 10.14Regular26.10.14 23:41SCHEDULE 13GOwnership
Sunshine Biopharma Inc.
BJI Financial Group has filed a Schedule 13G regarding its beneficial ownership of Sunshine Biopharma Inc. shares. This filing serves as an official disclosure of the investor's stake in the company.…more
$0.1449-1.16%vs prev closeView filingShare
35 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 2d agoPre-market26.10.22 22:02Bullish#●●●
Sunshine Biopharma Announces 1-for-20 Reverse Stock Split
Sunshine Biopharma will implement a 1-for-20 reverse stock split effective October 26. This corporate action reduces the number of outstanding shares to increase the per-share price.…more
$0.1449-1.16%vs prev closeDetected5m · 30m · 60m · Next dayPLUSShareBenzinga
- 10.8Pre-market26.10.08 21:01
●●●●●●●● ●●●●● ●●●●●●
Sunshine Biopharma has priced a public offering of approximately 10.9 million units at $0.55 per unit to raise $6 million. Each unit includes two warrants, which may lead to potential share dilution.…more
$0.1449-1.16%vs prev closeShareBenzinga - 9.28Pre-market26.09.28 19:28
●●●●●●●● ●●●●● ●●●●●●
Sunshine Biopharma has received shareholder approval to amend its articles of incorporation to effect a reverse stock split of up to 1-for-20. The board of directors retains the discretion to determine whether to implement the split and the final ratio.…more
$0.1449-1.16%vs prev closeShareBenzinga
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report